The small volume parenteral global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Small Volume Parenteral Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The small volume parenteral market size has grown strongly in recent years. It will grow from 163.34 billion in 2023 to $177.26 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, regulatory approvals and government initiatives, pharmaceutical outsourcing trends, and globalization and expansion of pharmaceutical markets.
The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $247.53 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the expansion of the biologics market, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, a shift toward home healthcare, rising investment in healthcare, and global health crises. Major trends in the forecast period include growth in biocompatible formulations, patient-centric approaches, rise in home healthcare, advancements in manufacturing automation, expansion in therapeutic areas, and smart pump technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Scope Of Small Volume Parenteral Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Small Volume Parenteral Market Overview
Market Drivers –
The increasing number of surgeries is expected to propel the growth of the small-volume parenteral market going forward. Surgery is a medical specialty that involves using operative techniques to investigate or treat a pathological condition such as disease or injury, improve bodily function or appearance, or repair unwanted ruptured areas. The rate of surgeries is rising due to advancements in medical technology and an aging population, increasing the demand for surgical interventions. Small-volume parenteral solutions are used in surgeries to precisely administer medications, electrolytes, and nutrients directly into the bloodstream. For instance, in February 2022, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based organization, an estimated 1.4 million surgical and non-surgical plastic surgeries were performed in 2021, with plastic surgeons completing an average of 600 more procedures compared to 2020. Therefore, the increasing number of surgeries is driving the growth of the small-volume parenteral market.
Market Trends –
Major companies operating in the small volume parenteral market are focusing on developing innovative solutions, such as Pharmatec SVP process systems, to maximize their revenues in the market. Pharmatec SVP process systems are specialized solutions designed to produce small-volume parenteral (SVP) pharmaceuticals. These systems are tailored to meet the stringent requirements of sterile manufacturing processes, ensuring high quality and safety standards for injectable products. For instance, in March 2021, Syntegon, a Germany-based machine industry company, launched the SVP Essential, a small-volume parenteral pharmaceutical production system designed for cost-efficiency and high quality. This system offers a fully automated, ready-to-use solution with the highest hygienic standards and reproducibility throughout the process. It is particularly suitable for producing simple parenteral drugs such as analgesics, insulin, and generic drugs, with a modular design allows delivery in just six months.
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Get an inside scoop of the small volume parenteral market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp
Regional Insights –
North America was the largest region in the small volume parenteral market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
Table of Contents
1. Executive Summary
2. Small Volume Parenteral Market Report Structure
3. Small Volume Parenteral Market Trends And Strategies
4. Small Volume Parenteral Market – Macro Economic Scenario
5. Global Small Volume Parenteral Market Size and Growth
.
.
.
32. Global Small Volume Parenteral Market Competitive Benchmarking
33. Global Small Volume Parenteral Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Small Volume Parenteral Market
35. Small Volume Parenteral Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
